Empagliflozin Treatment in Kidney Transplant Recipients
Conditions: Kidney Transplant; Type 2 Diabetes Intervention: Drug: Empagliflozin Sponsors: VA Office of Research and Development; Iowa City VA Health Care System; VA Pittsburgh Healthcare System; Nashville VA Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
Repurposing Empagliflozin and Dapagliflozin for Paediatric Heart Failure: Translational Approach and Dose Rationale
Condition: Heart Failure Interventions: Drug: Dapagliflozin tablet; Drug: Empagliflozin Tablets Sponsors: Centre Hospitalier Universitaire Vaudois; Great Ormond Street Hospital for Children NHS Foundation Trust; University College, London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials